Market News
Amicus Therapeutics (FOLD): FY 2019 Earnings Snapshot
— Biotechnology company Amicus Therapeutics (NASDAQ: FOLD) reported a net loss of $356.4 million or $1.48 per share for fiscal 2019, compared to a loss…